Evaluation of TNF-α effects on radiation efficacy in a human lung adenocarcinoma model

Oncology Research

Volumn 8, Issue 12, 1996, Pages 485-495

  Gridley, Daila S ^a   Andres, Melba L ^a   Garner, Cheryl ^a   Mao, Xiao Wen ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; lung adenocarcinoma; radiation; TNF ; xenograft

Indexed keywords

OXYGEN RADICAL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CLONOGENIC ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION DOSE; SPLEEN CELL; TUMOR XENOGRAFT;

EID: 0030440393     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. 1. American Cancer Society. Cancer facts & figures - 1995. Atlanta, GA: American Cancer Society, Inc. 1-28, 1995.
2. 2. Belani, C. P. Multimodality management of regionally advanced nonsmall-cell lung cancer. Semin. Oncol. 20:302-314; 1993.
3. 3. McDonald, S.; Rubin, P.; Phillips, T. L.; Marks, L. B. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int. J. Radiat. Oncol. Biol. Phys. 31:1187-1203; 1995.
4. 4. Benfield, J. R.; Decaro, L. F. Respiratory tract neoplasms. In: Moossa, A. R.; Schimpff, S. C.; Robson, M. C., eds. Comprehensive textbook of oncology. Vol. 1, 2nd ed. Baltimore, MD: Williams & Wilkins; 1991:pp. 732-752.
5. 5. Hallahan, D. E.; Haimovitz-Friedman, A.; Kufe, D. W.; Fuks, Z.; Weichselbaum, R. R. The role of cytokines in radiation oncology. In: DeVita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Important advances in oncology 1993. Philadephia: J. B. Lippincott Co.; 1993:pp. 71-80.
6. 6. Carswell, E. A.; Old, L. J.; Russel, R. L.; Green, M.; Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666-3670; 1975.
7. 7. Old, L. J. Antitumor activity of microbial products and tumor necrosis factor. In: Bonavida, B.; Gifford, G. E.; Kircher, H.; Old, L. J., eds. Tumor necrosis factor/cachectin and related cytokines. Basel: S. Karger; 1988:pp. 7-19.
8. 8. Old, L. J. Tumor necrosis factor. Science 230:630-634; 1985.
9. 9. Sugarman, H. J.; Aggarwal, B. B.; Hass, P. E.; Figari, I. S.; Palladino, M. A., Jr.; Shepard, H. M. Recombinant human tumor necrosis factor: effects on proliferation of normal and transformed cells in vitro. Science 230:943-945; 1985.
10. 10. Kronke, M.; Schutze, S.; Scheurich, P.; Pfizenmaier, K. TNF signal transduction and TNF-responsive genes. Immunol. Ser. 56:189-21; 1992.
11. 11. Panek, R. B.; Lee, Y. J.; Itoh-Lindstrom, Y.; Ting, J. P. Y.; Benveniste, E. N. Characterization of astrocyte nuclear proteins involved in IFN-γ- and TNF-α-mediated class II MHC gene expression. J. Immunol. 153:4555-4564; 1994.
12. 12. Pilaro, A. M.; Taub, D. D.; McCormick, K. L.; Williams, H. M.; Sayers, T. J.; Fogler, W. E.; Wiltrout, R. H. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153:333-341; 1994.
13. 13. Hernandez-Caselles, T.; Stutman, O. Immune functions of tumor necrosis factor. J. Immunol. 151:3999-4012; 1995.
14. 14. Tracey, K. J.; Fong, Y.; Hesse, D. G.; Manogue, K. R.; Lee, A. T.; Kuo, G. C.; Lowry, S. F.; Cerami, A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-664; 1987.
15. 15. Van der Schelling, G. P.; Ijzermans, J. N. M.; Kok, T.C.; Scheringa, M.; Marquet, R. L.; Splinter, T. A. W.; Jeekel, J. A phase I study of local treatment of liver metastases with recombinant tumor necrosis factor. Eur. J. Cancer 28A:1073-1078; 1992.
16. 16. Watanabe, N.; Yamauchi, N.; Maeda, M.; Neda, H.; Tsuji, Y.; Okamoto, T.; Tsuji, N.; Akiyama, S.; Sasaki, H.; Niitsu, Y. Recombinant human tumor necrosis factor causes regression in patients with advanced malignancies. Oncology 51:360-365; 1994.
17. 17. Seiberl, N. L.; Dinndorf, P. A.; Bauer, M.; Sondel, P. M.; Hammond, G. D.; Reaman, G. H. Phase I study of tumor necrosis factor-α and actinomycin D in pediatric patients with cancer: a children's cancer group study. J. Immunother. 16:125-131; 1994.
18. 18. Jarvis, W. D.; Grant, S.; Kolesnick, R. N. Ceramide and the induction of apoptosis (minireview). Clin. Cancer Res. 2:1-6; 1996.
19. 19. Zimmerman, R. J.; Chan, A.; Leadon, S. A. Oxidative damage in murine tumor cells treated in vitro by recombinant human TNF. Cancer Res. 49:1644-1648; 1989.
20. 20. Sarraf, C. E. Tumor necrosis factor and cell death in tumours (review). Int. J. Oncol. 5:1333-1339; 1994.
21. 21. Meyn, R. E.; Milas, L.; Story, M. D.; Kian, K. K.; Tomasovic, S. P.; Stephens, L. C. Programmed cell death in response of normal and tumor tissue to radiation. Cancer Bull. 44:80-85; 1992.
22. 22. Soldatenkov, V. A.; Prasad, S.; Notario, V.; Dritschilo, A. Radiation-induced apoptosis of Ewing's sarcoma cells: DNA fragmentation and proteolysis of poly(ADP-ribose) polymerase. Cancer Res. 55:4240-4242; 1995.
23. 23. Gridley, D. S.; Hammond, S. N.; Liwnicz, B. Effects of tumor necrosis factor-α and radiation on human tumor xenografts. Anticancer Res. 14:1107-1112; 1994.
24. 24. Gridley, D. S.; Glisson, W. C.; Uhm, J-R. Interaction of tumor necrosis factor-α and radiation against human colon tumor cells. Therapeutic Immunol. 1:25-31; 1994.
25. 25. Gridley, D. S.; Andres, M. L.; Mao, T. W.; Slater, J. M. Tumor necrosis factor-α and radiation: comparison of efficiency in three tumor xenograft models. FASEB J. 10:A1348; 1996.
26. 26. Sersa, G.; Willingham, V.; Milas, L. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy. Int. J. Cancer 42:129-134; 1988.
27. 27. Hallahan, D. E.; Beckett, M. A.; Kufe, D.; Weichselbaum, R. R. The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 19:69-74; 1990.
28. 28. Wan, C. P.; Myung, E.; Lau, B. H. S. An automated microfluorometric assay for monitoring oxidative burst activity of phagocytes. J. Immunol. Meth. 159:131-138; 1993.
29. 29. Hallahan, D. E.; Vokes, E. E.; Rubin, S. J.; O'Brien, S.; Samuels, B.; Vijaykumar, S.; Kufe, D. W.; Phillips, R.; Weichselbaum, R. R. Phase I dose-escalation study of tumor necrosis factor-α and concomitant radiation therapy. Cancer J. 1:204-209; 1995.
30. 30. International Workshop on Cytokines. Oppenheim, J. J., ed. Molecular and cellular biology of cytokines: from the proceedings of the Second International Workshop on Cytokines. New York: Wiley-Liss; 1990:pp. 275-280.
31. 31. Fujiki, H.; Suganuma, M. Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid. J. Biochem. (Tokyo) 115:1-5; 1994.
32. 32. Rosenberg, S. A. Immunotherapy and gene therapy of cancer. Cancer Res. (18 suppl) 51:5074s-5079s; 1991.
33. 33. Yin, D.; Kondo, S.; Barnett, G. H.; Morimura, T.; Takeuchi, J. Tumor necrosis factor-α induces p53-dependent apoptosis in rat glioma cells. Neurosurgery 37: 758-763; 1995.
34. 34. Ishida, Y.; Agata, Y.; Shibahara, K.; Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:3887-3895; 1992.
35. 35. Kondo, S.; Yin, D.; Morimura, T.; Kubo, H.; Nakatsu, S.; Takeuchi, J. Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br. J. Cancer 71:282-289; 1995.
36. 36. Lowe, S. W.; Schmitt, E. M.; Smith, S. W.; Osborne, B. A.; Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849; 1993.
37. 37. Brockhaus, M.; Schoenfeld, H. J.; Schlaeger, E. J.; Hunziker, W.; Lesslauer, W.; Loetscher, H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127-3131; 1990.
38. 38. Gruss, H.-J.; Dower, S. K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378-3404; 1995.
39. 39. Dembic, Z. H.; Loetscher, H.; Gubler, U.; Pan, Y.-C. E.; Lahm, H.-W.; Gentz, R.; Brockhaus, M.; Lesslauer, W. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2: 231-237; 1990.
40. 40. Espevik, T.; Brockhaus, M.; Loetscher, H.; Nostad, U.; Shalaby, R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415-426; 1990.
41. 41. Smith, C. A.; Farrah, T.; Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962; 1994.
42. 42. Heller, R. A.; Song, K.; Fan, N.; Chang, D. J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56; 1992.
43. 43. Sarraf, C. E.; Bowen, I. D. Occurrence of apoptosis in tumours and its effect on neoplastic development. In: Columbano, A.; Feo, F.; Pascale, R.; Pani, P., eds. Chemical carcinogenesis 2, modulating factors. New York: Plenum Press:pp. 553-562; 1991.
44. 44. Zimmerman, R. J.; Chan, A.; Leadon, S. A. Oxidative damage in murine tumor cells treated in vitro by recombinant human TNF. Cancer Res. 49:1644-1648; 1989.
45. 45. Alon, R.; Cahalon, L.; Hershkoviz, R.; Elbaz, D.; Reizis, B.; Wallach, D.; Akiyama, S. K.; Yamada, K. M.; Lider, O. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1 integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J. Immunol. 152:1304-1313; 1994.
46. 46. Birkedal-Hansen, H. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodont. Res. 28: 5001-510; 1993.
47. 47. Buttke, T. M.; Sandstrom, P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7-10; 1994.
48. 48. McIlwrath, A. J.; Vasey, P. A.; Ross, G. M.; Brown, R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res. 54:3718-3722; 1994.
49. 49. Yount, G. L.; Haas-Kogan, D. A.; Vidair, C. A.; Maas, M.; Dewey, W. C.; Israel, M. A. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 56: 500-506; 1996.
50. 50. Laster, S. N.; Wood, J. G.; Gooding, L. R. Tumour necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol. 141:2629-2634; 1988.